Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for the ...

Lars is a bloodhound when it comes to sniffing out bargains, including on major sales events such as Black Friday and Amazon Prime Day. He is also handy at unravelling tech jargon and anything related ...